Clinical Trial: Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia Areata

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional



Official Title: A Two Stage Phase II Randomized Bilateral Comparison of Topical Targretin® Gel 1% in Alopecia Areata

Brief Summary:

The goal of this clinical research study is to find the most effective dose of Targretin® (bexarotene) Gel 1% that can be given to patients as a treatment for alopecia areata. The safety and tolerability of this drug will also be studied.

Objectives:

  1. Determine the safety and tolerability of Targretin® Gel 1% in the treatment of patients with alopecia areata.
  2. Determine the efficacy of Targretin® Gel 1% in the treatment of patients with alopecia areata.